Health
Moderna coronavirus vaccine candidate moves to phase 3 with 30,000 participants – News-Medical.Net
The world’s most significant coronavirus disease (COVID-19) vaccine study is underway in the United States, with a planned 30,000 volunteers. The phase 3 clinical trial aims to examine the efficacy and safety of the candidate vaccine developed by the National…
The world’s most significant coronavirus disease (COVID-19) vaccine study is underway in the United States, with a planned 30,000 volunteers. The phase 3 clinical trial aims to examine the efficacy and safety of the candidate vaccine developed by the National Institutes of Health and Moderna Inc.
The U.S. biotech firm Moderna announced that it had started the final stage of its human trials for its experimental COVID-19 vaccine in the U.S. The phase 3 human clinical trial comes after the compan…
-
Noosa News18 hours agoGippsland vegetable farm accused of underpaying migrant workers
-
General19 hours agoFour escape injury after jumping from three-storey unit on fire in Newcastle
-
General24 hours agoDe-escalation skills, not guards, needed in Tasmanian hospitals, nurses’ union says
-
General11 hours agoMan refused bail charged with depicting Adolf Hitler and Nazi symbols on boat